Investors in Insys Therapeutics Inc (INSY) saw new options begin trading this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the INSY options chain for the new November 17th contracts and identified one put and one call contract of particular interest.The put contract at the $4.00 strike price has a current bid of 5 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $4.00, but will also collect the premium, putting the cost basis of the shares at $3.95 (before broker commissions). To an investor already interested in purchasing shares of INSY, that could represent an attractive alternative to paying $10.14/share today. Because the $4.00 strike represents an approximate 61% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 95%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 1.25% return on the cash commitment, or 1.89% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Insys Therapeutics Inc, and highlighting in green where the $4.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $12.00 strike price has a current bid of 15 cents. If an investor was to purchase shares of INSY stock at the current price level of $10.14/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $12.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 19.82% if the stock gets called away at the November 17th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if INSY shares really soar, which is why looking at the trailing twelve month trading history for Insys Therapeutics Inc, as well as studying the business fundamentals becomes important. Below is a chart showing INSY's trailing twelve month trading history, with the $12.00 strike highlighted in red: Considering the fact that the $12.00 strike represents an approximate 18% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 43%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 1.48% boost of extra return to the investor, or 2.24% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 170%, while the implied volatility in the call contract example is 94%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $10.14) to be 71%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Replay: Jim Cramer on Earnings Season, China and Amazon Prime Day
Jim Cramer's breaking down what he expects from earnings season, China's slowing growth, and Amazon's Prime day sale.
Prime Day Isn't Just For Amazon -- Target, Walmart, Others Want a Piece Too
Amazon's retail competitors will see a 79% revenue lift around Prime Day, according to a projection from Adobe Analytics.
Jim Cramer: Even if Slowdown Hits, You'll Look Good With These Six Stocks
Estee Lauder is among the companies that are sure winners, no matter which way the economy goes.
Slack Rallies by 3% as Research Firms Initiate Bullish Coverage
Canaccord, Barclays and William Blair all published bullish notes on the messaging service, which went public via a direct listing in June.
Earnings to Soon Give Insight into Market's Strength
Are we seeing low-volume consolidation setting stage for thrust higher or is this stalling action suggesting a rollover? The answer depends on how earnings season develops.